887 related articles for article (PubMed ID: 8352523)
21. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
22. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
Sapi E; Flick MB; Tartaro K; Kim S; Rakhlin Y; Rodov S; Kacinski BM
Cancer Res; 1999 Nov; 59(21):5578-85. PubMed ID: 10554038
[TBL] [Abstract][Full Text] [Related]
23. Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL 60 cells.
Studzinski GP; Brelvi ZS
J Natl Cancer Inst; 1987 Jul; 79(1):67-76. PubMed ID: 3474450
[TBL] [Abstract][Full Text] [Related]
24. Modification of proto-oncogene expression by phorbol esters in human dermal microvascular endothelial cells.
Mansbridge JN; Grymes RA; Karasek MA
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):791-8. PubMed ID: 1472905
[TBL] [Abstract][Full Text] [Related]
25. Absence of phorbol ester-induced down-regulation of myc protein in the phorbol ester-tolerant mutant of HL-60 promyelocytes.
Gailani D; Cadwell FJ; O'Donnell PS; Hromas RA; Macfarlane DE
Cancer Res; 1989 Oct; 49(19):5329-33. PubMed ID: 2670202
[TBL] [Abstract][Full Text] [Related]
26. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
Chen Q; DeFrances MC; Zarnegar R
Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
[TBL] [Abstract][Full Text] [Related]
27. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
Curran T; Bravo R; Müller R
Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of the c-fms proto-oncogene mediated by granulocyte/macrophage colony-stimulating factor (GM-CSF) in murine cell lines.
Helftenbein G; Krusekopf K; Just U; Cross M; Ostertag W; Niemann H; Tamura T
Oncogene; 1996 Feb; 12(4):931-5. PubMed ID: 8632916
[TBL] [Abstract][Full Text] [Related]
29. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
Goode NT; Moore JP; Hart IR
Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
[TBL] [Abstract][Full Text] [Related]
31. Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene.
Rohrschneider LR; Rothwell VM; Nicola NA
Oncogene; 1989 Aug; 4(8):1015-22. PubMed ID: 2548144
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional down-regulation of c-myc expression by protein synthesis-dependent and -independent pathways in a human T lymphoblastic tumor cell line.
Bading H; Moelling K
Cell Growth Differ; 1990 Mar; 1(3):113-7. PubMed ID: 2127692
[TBL] [Abstract][Full Text] [Related]
33. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
34. Gene modulation accompanying differentiation of normal versus malignant keratinocytes.
Yaar M; Gilani A; DiBenedetto PJ; Harkness DD; Gilchrest BA
Exp Cell Res; 1993 Jun; 206(2):235-43. PubMed ID: 8500546
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cells.
Wang XH; Whyzmuzis CA; An S; Chen Y; Wu JM; Schneidau TA; Mallouh C; Tazaki H
Biochem Mol Biol Int; 1994 Aug; 34(1):47-53. PubMed ID: 7849624
[TBL] [Abstract][Full Text] [Related]
36. [Toward a new definition of malignant histiocytosis in children].
Nezelof C
Bull Mem Acad R Med Belg; 1992; 147(11-12):472-8; discussion 478-80. PubMed ID: 1341571
[TBL] [Abstract][Full Text] [Related]
37. The 5q35bp chromosomal abnormality characterizes certain CD30 positive anaplastic large cell lymphomas offering a new definition of malignant histiocytosis in childhood.
Nezelof C
Nouv Rev Fr Hematol (1978); 1993; 35(5):463-7. PubMed ID: 8295819
[TBL] [Abstract][Full Text] [Related]
38. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
39. Regulation of proliferation in a murine colony-stimulating factor-dependent myeloid cell line: superinduction of c-fos by the growth inhibitor 8-Br-cyclic adenosine 3':5' monophosphate.
Harel-Bellan A; Farrar WL
J Cell Biochem; 1988 Nov; 38(3):145-53. PubMed ID: 3068231
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
